documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
162 rows where agency_id = "FDA" and posted_year = 1995 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, comment_start_date, comment_end_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 5
- Other 66
- Supporting & Related Material 46
- Notice 45
- Proposed Rule 4
- Rule 1
posted_year 1
- 1995 · 162 ✖
agency_id 1
- FDA · 162 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1994-P-0043-0007 | FDA | Adopt Amendments Governing Health Claims & Nutrient Claims FDA-1994-P-0043 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1995-12-28T05:00:00Z | 1995 | 12 | 1995-12-28T05:00:00Z | 1996-03-21T04:59:59Z | 2008-05-16T23:21:21Z | 0 | 0 | 09000064804ff4ac | |
| FDA-1994-P-0043-0006 | FDA | Adopt Amendments Governing Health Claims & Nutrient Claims FDA-1994-P-0043 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1995-12-28T05:00:00Z | 1995 | 12 | 1995-12-28T05:00:00Z | 1996-03-21T04:59:59Z | 2008-05-16T23:21:15Z | 0 | 0 | 09000064804ff4ab | |
| FDA-1994-P-0043-0008 | FDA | Adopt Amendments Governing Health Claims & Nutrient Claims FDA-1994-P-0043 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1995-12-28T05:00:00Z | 1995 | 12 | 1995-12-28T05:00:00Z | 1996-03-21T04:59:59Z | 2008-05-16T23:21:16Z | 0 | 0 | 09000064804ff4ad | |
| FDA-1994-P-0043-0004 | FDA | Adopt Amendments Governing Health Claims & Nutrient Claims FDA-1994-P-0043 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1995-12-28T05:00:00Z | 1995 | 12 | 1995-12-28T05:00:00Z | 1996-03-21T04:59:59Z | 2008-05-16T23:21:16Z | 0 | 0 | 09000064804ff4a9 | |
| FDA-1994-P-0043-0010 | FDA | Adopt Amendments Governing Health Claims & Nutrient Claims FDA-1994-P-0043 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1995-12-28T05:00:00Z | 1995 | 12 | 1995-12-28T05:00:00Z | 1996-03-21T04:59:59Z | 2008-05-16T23:21:18Z | 0 | 0 | 09000064804ff4af | |
| FDA-1994-P-0043-0005 | FDA | Adopt Amendments Governing Health Claims & Nutrient Claims FDA-1994-P-0043 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1995-12-28T05:00:00Z | 1995 | 12 | 1995-12-28T05:00:00Z | 1996-03-21T04:59:59Z | 2008-05-16T23:21:21Z | 0 | 0 | 09000064804ff4aa | |
| FDA-1994-P-0043-0009 | FDA | Adopt Amendments Governing Health Claims & Nutrient Claims FDA-1994-P-0043 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1995-12-28T05:00:00Z | 1995 | 12 | 1995-12-28T05:00:00Z | 1996-03-21T04:59:59Z | 2008-05-16T23:21:21Z | 0 | 0 | 09000064804ff4ae | |
| FDA-1978-N-2157-0006 | FDA | Skin Protectant Drug Proposed Rulemaking for Diaper Rash FDA-1978-N-2157 | Acknowledgement Letter FDA/DDM to The Proctor & Gamble Company | Other | Acknowledgement Letter/Receipt | 1995-12-22T05:00:00Z | 1995 | 12 | 2019-08-01T18:37:54Z | 0 | 0 | 09000064805a6715 | |||
| FDA-1978-N-2157-0004 | FDA | Skin Protectant Drug Proposed Rulemaking for Diaper Rash FDA-1978-N-2157 | Acknowledgement Letter FDA/DDM to Huls America, Inc. | Other | Acknowledgement Letter/Receipt | 1995-12-22T05:00:00Z | 1995 | 12 | 2019-08-01T18:45:05Z | 0 | 0 | 09000064805a6713 | |||
| FDA-1978-N-2157-0005 | FDA | Skin Protectant Drug Proposed Rulemaking for Diaper Rash FDA-1978-N-2157 | Acknowledgment Letter from FDA/DDM to Smith & Nephew United Inc. re: Citizen Petition from Smith & Nephew United, Inc. | Other | Acknowledgement Letter/Receipt | 1995-12-22T05:00:00Z | 1995 | 12 | 2019-06-03T13:50:38Z | 0 | 0 | 09000064805a6714 | |||
| FDA-1980-N-0074-0035 | FDA | Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 | FDA | Notice | NCR-Notice of Correction | 1995-12-05T05:00:00Z | 1995 | 12 | 2008-05-30T22:53:09Z | 0 | 0 | 09000064805bb3ca | |||
| FDA-1993-N-0064-0002 | FDA | Prescription Drug Product; Medication Guide Requirements FDA-1993-N-0064 | FDA | Notice | NEC-Notice of Extension | 1995-12-05T05:00:00Z | 1995 | 12 | 1995-11-24T05:00:00Z | 1995-12-23T04:59:59Z | 2008-05-16T23:24:21Z | 0 | 0 | 09000064804fca32 | |
| FDA-1993-N-0064-0001 | FDA | Prescription Drug Product; Medication Guide Requirements FDA-1993-N-0064 | FDA | Notice | NEC-Notice of Extension | 1995-12-05T05:00:00Z | 1995 | 12 | 1995-11-24T05:00:00Z | 1995-12-23T04:59:59Z | 2008-05-16T23:24:20Z | 0 | 0 | 09000064804fc9b0 | |
| FDA-1988-P-0013-0049 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:21Z | 0 | 0 | 0900006480475bb3 | |||
| FDA-1988-P-0013-0045 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:21Z | 0 | 0 | 0900006480475ba6 | |||
| FDA-1988-P-0013-0048 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:07Z | 0 | 0 | 0900006480475bad | |||
| FDA-1988-P-0013-0058 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:52:52Z | 0 | 0 | 0900006480475bc5 | |||
| FDA-1988-P-0013-0059 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:21Z | 0 | 0 | 0900006480475bc6 | |||
| FDA-1988-P-0013-0004 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | FDA | Notice | NFR-Notice of Final Rule | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:00Z | 0 | 0 | 0900006480475b27 | |||
| FDA-1988-P-0013-0057 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:21Z | 0 | 0 | 0900006480475bc4 | |||
| FDA-1988-P-0013-0060 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:07Z | 0 | 0 | 0900006480475bc7 | |||
| FDA-1988-P-0013-0054 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:52:52Z | 0 | 0 | 0900006480475bc0 | |||
| FDA-1988-P-0013-0061 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:00Z | 0 | 0 | 0900006480475bc8 | |||
| FDA-1988-P-0013-0006 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | FDA | Notice | NFR-Notice of Final Rule | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:00Z | 0 | 0 | 0900006480475b29 | |||
| FDA-1988-P-0013-0046 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:28Z | 0 | 0 | 0900006480475ba8 | |||
| FDA-1988-P-0013-0055 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:21Z | 0 | 0 | 0900006480475bc2 | |||
| FDA-1988-P-0013-0040 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:00Z | 0 | 0 | 0900006480475b99 | |||
| FDA-1988-P-0013-0041 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:28Z | 0 | 0 | 0900006480475b9c | |||
| FDA-1988-P-0013-0053 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:52:52Z | 0 | 0 | 0900006480475bbf | |||
| FDA-1988-P-0013-0062 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:00Z | 0 | 0 | 0900006480475bc9 | |||
| FDA-1988-P-0013-0047 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:52:36Z | 0 | 0 | 0900006480475baa | |||
| FDA-1988-P-0013-0051 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:28Z | 0 | 0 | 0900006480475bb8 | |||
| FDA-1988-P-0013-0056 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:14Z | 0 | 0 | 0900006480475bc3 | |||
| FDA-1988-P-0013-0050 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:52:45Z | 0 | 0 | 0900006480475bb5 | |||
| FDA-1988-P-0013-0044 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:52:52Z | 0 | 0 | 0900006480475ba3 | |||
| FDA-1988-P-0013-0043 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:52:45Z | 0 | 0 | 0900006480475ba0 | |||
| FDA-1988-P-0013-0052 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:00Z | 0 | 0 | 0900006480475bba | |||
| FDA-1995-N-0049-0001 | FDA | Beverages: Bottled Water FDA-1995-N-0049 | Beverages: Bottled Water | Notice | NPR-Notice of Proposed Rule-Making | 1995-11-29T05:00:00Z | 1995 | 11 | 1995-11-13T05:00:00Z | 1996-01-30T04:59:59Z | 2024-07-16T14:08:13Z | 95-27799 | 0 | 0 | 0900006480561cac |
| FDA-1988-P-0013-0005 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | FDA | Notice | NFR-Notice of Final Rule | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:21Z | 0 | 0 | 0900006480475b28 | |||
| FDA-1995-N-0049-0002 | FDA | Beverages: Bottled Water FDA-1995-N-0049 | Reference 1 - Humphreys, S., Contaminants, Standards, and Monitoring Branch (HFS-308F), Center for Food Safety and Applied Nutrition, Food and Drug Administration, memo to Shellee Davis, May 26, 1995. | Notice | NPR-Notice of Proposed Rule-Making | 1995-11-29T05:00:00Z | 1995 | 11 | 2024-07-16T14:13:41Z | 0 | 0 | 0900006480561ccb | |||
| FDA-1988-P-0013-0042 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:52:52Z | 0 | 0 | 0900006480475b9e | |||
| FDA-1988-P-0013-0063 | FDA | Amend Regs re: Standards of Quality of Bottled Water FDA-1988-P-0013 | Background Material for NFR1 | Supporting & Related Material | BKG-Background Material | 1995-11-29T05:00:00Z | 1995 | 11 | 2008-05-30T22:52:45Z | 0 | 0 | 0900006480475bca | |||
| FDA-1995-G-0040-0001 | FDA | 25-hydroxyvitamin D3 be affirmed as GRAS FDA-1995-G-0040 | Amoco Bioproducts Corp. | Notice | NFL-Notice of Filing | 1995-11-28T05:00:00Z | 1995 | 11 | 1995-10-23T04:00:00Z | 1996-01-09T04:59:59Z | 2008-05-16T22:22:17Z | 0 | 0 | 0900006480560ff7 | |
| FDA-1995-P-0044-0003 | FDA | Modify Advice Bioequivalence of generic ammonium lactate-CLOSED FDA-1995-P-0044 | FDA/DDM to Westwood Squibb Pharmaceuticals, Inc | Other | ACK-Acknowledgement Letter | 1995-11-27T05:00:00Z | 1995 | 11 | 2008-05-16T23:07:30Z | 0 | 0 | 090000648056143f | |||
| FDA-1980-N-0074-0033 | FDA | Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 | FDA | Notice | NFR-Notice of Final Rule | 1995-11-27T05:00:00Z | 1995 | 11 | 2008-05-30T22:52:47Z | 0 | 0 | 09000064805bb3c8 | |||
| FDA-1980-N-0074-0034 | FDA | Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 | FDA | Notice | NFR-Notice of Final Rule | 1995-11-27T05:00:00Z | 1995 | 11 | 2008-05-30T22:53:02Z | 0 | 0 | 09000064805bb3c9 | |||
| FDA-1978-N-0018-0144 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from The Assembly State of New York, Albany to FDA | Other | Letter(s) | 1995-11-22T05:00:00Z | 1995 | 11 | 2019-07-23T18:14:02Z | 0 | 0 | 090000648055a251 | |||
| FDA-1995-P-0023-0001 | FDA | Add Terminal Dry-Heat Inactivation of Plasma-Derived Factor8-CLOSED FDA-1995-P-0023 | HFA-305 to Columbia University of School of Public Health | Other | ACK-Acknowledgement Letter | 1995-11-20T05:00:00Z | 1995 | 11 | 2008-05-16T23:07:11Z | 0 | 0 | 0900006480559662 | |||
| FDA-1995-P-0010-0001 | FDA | Current Good Manufacturing Practices Regulations for Medicated Feeds FDA-1995-P-0010 | Acknowledgement Letter to American Feed Industry Association and Animal Health Institute | Other | ACK-Acknowledgement Letter | 1995-11-14T05:00:00Z | 1995 | 11 | 2013-07-28T01:44:10Z | 0 | 0 | 090000648055842e | |||
| FDA-1978-N-0018-0143 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Memorandum of Meeting Between FDA and Givaudan-Roure Corporation et al August 11, 1995 | Other | Memorandum | 1995-11-01T05:00:00Z | 1995 | 11 | 2019-07-23T16:14:40Z | 0 | 0 | 090000648055a248 | |||
| FDA-1995-P-0042-0001 | FDA | Regulate Caffeine Beverages as Drugs and/or Devices-CLOSED FDA-1995-P-0042 | Acknowledgment Letter from FDA DMB to Competitive Enterprise Institute | Other | ACK-Acknowledgement Letter | 1995-10-31T05:00:00Z | 1995 | 10 | 2025-09-15T16:26:01Z | 0 | 0 | 090000648056126b | |||
| FDA-1982-P-0001-0011 | FDA | Bacitracin Zinc Premix FDA-1982-P-0001 | FDA/Associate Commissioner for Regulatory Affairs | Other | PDN-Petition Denial | 1995-10-27T04:00:00Z | 1995 | 10 | 2008-05-30T22:53:10Z | 0 | 0 | 090000648050d497 | |||
| FDA-1978-N-0018-0142 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from FDA CDER to the Honorable Audrey I. Pheffer & Harvey Weisenberg, New York State Assembly | Other | Letter(s) | 1995-10-26T04:00:00Z | 1995 | 10 | 2019-07-23T16:02:30Z | 0 | 0 | 090000648055a246 | |||
| FDA-1995-P-0004-0001 | FDA | ANDA Suitability for 2.5mg Hydrocodone Bitrate & 5mg Phenylephrine-CLOSED FDA-1995-P-0004 | Acknowledgement Letter from FDA DMB to Bock Pharmacal Co | Other | Acknowledgement Letter/Receipt | 1995-10-12T04:00:00Z | 1995 | 10 | 2024-06-06T01:00:29Z | 0 | 0 | 09000064805583cb | |||
| FDA-1995-S-0039-0050 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Reference I "Stevia Abstracts" Memorandum from FDA/CFSAN | Supporting & Related Material | Background Material | 1995-10-05T04:00:00Z | 1995 | 10 | 2016-09-30T14:19:54Z | 0 | 0 | 090000648055c206 | |||
| FDA-1980-N-0074-0032 | FDA | Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 | Letter from FDA HFD-811 to Cosmetic, Toiletry and Fragrance Association | Other | Letter(s) | 1995-10-04T04:00:00Z | 1995 | 10 | 2022-04-21T20:23:50Z | 0 | 0 | 09000064805bb362 | |||
| FDA-1995-S-0039-0001 | FDA | 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 | Memorandum from FDA/CFSAN | Other | M-Memorandum | 1995-09-27T04:00:00Z | 1995 | 9 | 2016-09-30T14:17:47Z | 0 | 0 | 090000648055bacf | |||
| FDA-1995-N-0031-0004 | FDA | OTC Bronchodilator Drug Products FDA-1995-N-0031 | Notice of Proposed rulemaking; extension of comment period re Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug products for Over-The-Counter Human use; proposed amendment of Monograph for OTC Bronchodilator Drug products; Extension of Comment period | Proposed Rule | Extension of Comment Period | 1995-09-27T04:00:00Z | 1995 | 9 | 1995-09-27T04:00:00Z | 2008-05-10T03:59:59Z | 2016-02-10T16:50:49Z | 0 | 0 | 090000648055a8dc | |
| FDA-1995-N-0014-0001 | FDA | Over the Counter Drug Labeling; Public Hearing FDA-1995-N-0014 | FDA | Notice | NCR-Notice of Correction | 1995-09-25T04:00:00Z | 1995 | 9 | 1995-09-25T04:00:00Z | 1995-10-31T04:59:59Z | 2008-05-16T22:22:27Z | 0 | 0 | 09000064805584ac | |
| FDA-1995-N-0021-0001 | FDA | Protection of Human Subjects; Informed Consent FDA-1995-N-0021 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1995-09-21T04:00:00Z | 1995 | 9 | 1995-09-21T04:00:00Z | 1995-11-07T04:59:59Z | 2008-05-16T22:22:34Z | 0 | 0 | 09000064805594aa | |
| FDA-1995-G-0001-0001 | FDA | Pullulanase Enzyme Derived from Bacillus licheniformis GRAS - Closed FDA-1995-G-0001 | Notice of Filing Solvay Enzymes, Inc. Filing of Petition for Affirmation of GRAS Status | Notice | Notice of Filing | 1995-08-31T04:00:00Z | 1995 | 8 | 1995-08-31T04:00:00Z | 1995-11-02T04:59:59Z | 2016-04-12T19:31:18Z | 0 | 0 | 090000648055830b | |
| FDA-1991-N-0037-0004 | FDA | Quality Assurance Public Workshop Re: Blood & Blood Products FDA-1991-N-0037 | FDA | Notice | NCR-Notice of Correction | 1995-08-30T04:00:00Z | 1995 | 8 | 2008-05-16T23:40:33Z | 0 | 0 | 0900006480529fdd | |||
| FDA-1993-N-0023-0003 | FDA | PMA of Cranial Electrotherapy Stimulators Effective Date FDA-1993-N-0023 | Neurological Devices; Effective Date of Requirement for Premarket Approval of Cranial Electrotherapy Stimulators; August 24, 1995 | Rule | Final Rule | 1995-08-29T04:00:00Z | 1995 | 8 | 2011-12-05T20:30:05Z | 0 | 0 | 09000064804fafd2 | |||
| FDA-1991-P-0020-0001 | FDA | Ban the Advertising of Prescription Drugs - CLOSED FDA-1991-P-0020 | Letter from FDA to Bass & Ullman on Behalf of National Association of Pharmaceutical Manufacturers | Other | Letter(s) | 1995-08-28T04:00:00Z | 1995 | 8 | 2023-11-16T21:52:45Z | 0 | 0 | 09000064805284a2 | |||
| FDA-1995-N-0031-0003 | FDA | OTC Bronchodilator Drug Products FDA-1995-N-0031 | Notice of Correction re Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human use; Proposed Amendment of Monograph for OTC Bronchodilator Drug Products | Notice | Correction | 1995-08-24T04:00:00Z | 1995 | 8 | 2016-02-12T19:14:24Z | 0 | 0 | 090000648055a826 | |||
| FDA-1995-P-0006-0003 | FDA | ANDA for Butalbital, Acetaminophen, Caffeine and Hydrocodone-CLOSED FDA-1995-P-0006 | Acknowledgment Letter from FDA DMB to Mikart, Inc. | Other | Acknowledgement Letter/Receipt | 1995-08-21T04:00:00Z | 1995 | 8 | 2025-09-19T00:46:55Z | 0 | 0 | 0900006480558400 | |||
| FDA-1995-P-0006-0002 | FDA | ANDA for Butalbital, Acetaminophen, Caffeine and Hydrocodone-CLOSED FDA-1995-P-0006 | Acknowledgment Letter from FDA DMB to Mikart, Inc. | Other | Acknowledgement Letter/Receipt | 1995-08-21T04:00:00Z | 1995 | 8 | 2025-09-19T00:46:31Z | 0 | 0 | 09000064805583ff | |||
| FDA-1995-P-0006-0004 | FDA | ANDA for Butalbital, Acetaminophen, Caffeine and Hydrocodone-CLOSED FDA-1995-P-0006 | Acknowledgment Letter from FDA DMB to Mikart, Inc. | Other | Acknowledgement Letter/Receipt | 1995-08-21T04:00:00Z | 1995 | 8 | 2025-09-19T00:47:17Z | 0 | 0 | 0900006480558401 | |||
| FDA-1995-P-0006-0001 | FDA | ANDA for Butalbital, Acetaminophen, Caffeine and Hydrocodone-CLOSED FDA-1995-P-0006 | Acknowledgment Letter from FDA DMB to Mikart, Inc. | Other | Acknowledgement Letter/Receipt | 1995-08-18T04:00:00Z | 1995 | 8 | 2025-09-19T00:45:55Z | 0 | 0 | 09000064805583f5 | |||
| FDA-1995-P-0002-0002 | FDA | Revise "Approved Drug Products" (known as "Orange Book")-CLOSED FDA-1995-P-0002 | HFA-305 to Kleinfeld, Kaplan & Becker | Other | ACK-Acknowledgement Letter | 1995-08-11T04:00:00Z | 1995 | 8 | 2008-05-16T23:06:15Z | 0 | 0 | 0900006480558353 | |||
| FDA-1995-P-0360-0002 | FDA | Regulatory Action to Prohibit Misleading Food Labeling FDA-1995-P-0360 | Acknowledgement Letter to Citizen Petition from Center for Science in the Public Interest | Other | Acknowledgement Letter/Receipt | 1995-08-04T04:00:00Z | 1995 | 8 | 2015-04-05T04:00:00Z | 2015-04-05T13:56:53Z | 0 | 0 | 0900006481a8be2c | ||
| FDA-1995-P-0360-0001 | FDA | Regulatory Action to Prohibit Misleading Food Labeling FDA-1995-P-0360 | Citizen Petition from Center for Science in the Public Interest | Other | Citizen Petition | 1995-08-04T04:00:00Z | 1995 | 8 | 2015-04-05T04:00:00Z | 2015-04-05T13:57:11Z | 0 | 0 | 090000648059a009 | ||
| FDA-1995-N-0031-0002 | FDA | OTC Bronchodilator Drug Products FDA-1995-N-0031 | Notice of Proposed rulemaking re Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug products for Over-The-Counter Human use; Proposed Amendment of Monograph for OTC Bronchodilator Drug products | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 1995-08-02T04:00:00Z | 1995 | 8 | 1995-08-02T04:00:00Z | 2008-05-10T03:59:59Z | 2016-02-10T16:37:10Z | 0 | 0 | 090000648055a7a0 | |
| FDA-1995-N-0031-0001 | FDA | OTC Bronchodilator Drug Products FDA-1995-N-0031 | Notice of Proposed Rulemaking re OTC Bronchodilator Drug Products | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 1995-08-02T04:00:00Z | 1995 | 8 | 1995-08-02T04:00:00Z | 1995-08-29T03:59:59Z | 2016-02-17T22:00:57Z | 0 | 0 | 090000648055a720 | |
| FDA-1995-P-0016-0003 | FDA | Implied Nutrient Content Claim 'Healthy' & Health Claims-CLOSED FDA-1995-P-0016 | HFA-305 | Other | ACK-Acknowledgement Letter | 1995-07-28T04:00:00Z | 1995 | 7 | 2008-05-16T23:06:36Z | 0 | 0 | 0900006480558657 | |||
| FDA-1990-N-0002-0006 | FDA | Revise Medical Device CGMP Regulation FDA-1990-N-0002 | FDA | Notice | NM-Notice of Meeting | 1995-07-27T04:00:00Z | 1995 | 7 | 1995-07-27T04:00:00Z | 1995-10-24T03:59:59Z | 2008-05-16T23:46:02Z | 0 | 0 | 090000648052558a | |
| FDA-1995-M-0007-0001 | FDA | PMA; Adatomed Silicone Oil OP5000 FDA-1995-M-0007 | Tab B: Approval Letter from FDA CDRH to Chiron Vision Corporation | Notice | Notice of Approval | 1995-07-27T04:00:00Z | 1995 | 7 | 1995-07-27T04:00:00Z | 1995-08-22T03:59:59Z | 2024-06-27T16:33:30Z | 0 | 0 | 0900006480558409 | |
| FDA-1995-M-0007-0002 | FDA | PMA; Adatomed Silicone Oil OP5000 FDA-1995-M-0007 | Tab C: Summary of Safety and Effectiveness Data | Notice | Notice of Approval | 1995-07-27T04:00:00Z | 1995 | 7 | 1995-07-27T04:00:00Z | 1995-08-22T03:59:59Z | 2024-06-27T16:34:56Z | 0 | 0 | 090000648055840b | |
| FDA-1995-M-0007-0003 | FDA | PMA; Adatomed Silicone Oil OP5000 FDA-1995-M-0007 | Chiron Vision Corp.; Premarket Approval of Adatomed Silicone Oil OP5000 | Notice | Notice of Approval | 1995-07-27T04:00:00Z | 1995 | 7 | 1995-07-27T04:00:00Z | 1995-08-22T03:59:59Z | 2024-06-27T16:29:51Z | 95-17832 | 0 | 0 | 090000648055840c |
| FDA-1991-N-0037-0003 | FDA | Quality Assurance Public Workshop Re: Blood & Blood Products FDA-1991-N-0037 | FDA | Notice | NAD-Notice of Availability of Data | 1995-07-26T04:00:00Z | 1995 | 7 | 2008-05-16T23:40:33Z | 0 | 0 | 0900006480529fda | |||
| FDA-1988-V-0025-0001 | FDA | Variance re Laser light show projector (LIP-88-1) FDA-1988-V-0025 | Approval for Variance from Laser Images Productions | Other | Approval for Variance (VRA) | 1995-07-20T04:00:00Z | 1995 | 7 | 2023-12-01T16:06:11Z | 0 | 0 | 09000064804763b9 | |||
| FDA-1995-P-0018-0002 | FDA | ANDA Suit for Hydrocodone Bitartrate & Acetaminophen-CLOSED FDA-1995-P-0018 | Acknowledgment Letter from FDA DMB to Mikart, Inc. | Other | Acknowledgement Letter/Receipt | 1995-07-20T04:00:00Z | 1995 | 7 | 2025-07-07T17:49:13Z | 0 | 0 | 09000064805592aa | |||
| FDA-1995-P-0018-0001 | FDA | ANDA Suit for Hydrocodone Bitartrate & Acetaminophen-CLOSED FDA-1995-P-0018 | Acknowledgment Letter from FDA DMB to Mikart, Inc. | Other | Acknowledgement Letter/Receipt | 1995-07-20T04:00:00Z | 1995 | 7 | 2025-10-11T08:00:48Z | 0 | 0 | 0900006480559274 | |||
| FDA-1978-N-0018-0141 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Letter from FDA CDER to Paul Pierce | Other | Letter(s) | 1995-07-13T04:00:00Z | 1995 | 7 | 2019-07-31T14:03:30Z | 0 | 0 | 090000648055a240 | |||
| FDA-1995-P-0017-0001 | FDA | Oat Products and Coronary Heart Disease FDA-1995-P-0017 | HFS-150 to The Quaker Oats Company | Other | ACK-Acknowledgement Letter | 1995-07-06T04:00:00Z | 1995 | 7 | 2008-05-16T23:06:49Z | 0 | 0 | 0900006480558802 | |||
| FDA-1981-F-0038-0001 | FDA | Safe Use of Epoxidized Soybean Oil FDA-1981-F-0038 | Food Additives Permitted for Direct Addition to Food for Human Consumption; Epoxidized Soybean Oil | Notice | Notice of Final Rule | 1995-06-29T04:00:00Z | 1995 | 6 | 1995-06-29T04:00:00Z | 1995-07-27T03:59:59Z | 2021-03-02T15:20:02Z | 95-15349 | 0 | 0 | 09000064805af256 |
| FDA-1981-F-0038-0002 | FDA | Safe Use of Epoxidized Soybean Oil FDA-1981-F-0038 | Background Material re Finding of No Significant Impact | Supporting & Related Material | Background Material | 1995-06-26T04:00:00Z | 1995 | 6 | 2021-03-02T15:02:45Z | 0 | 0 | 09000064805af258 | |||
| FDA-1995-P-0041-0001 | FDA | Exempt Medical Gases from the Requirements of 21 CFR 205-CLOSED FDA-1995-P-0041 | Acknowledgment Letter from FDA DDM to Compressed Gas Association, Inc. | Other | Acknowledgement Letter/Receipt | 1995-06-26T04:00:00Z | 1995 | 6 | 2017-02-14T15:24:15Z | 0 | 0 | 09000064805611af | |||
| FDA-1995-P-0035-0001 | FDA | Use URAA to Determine Approval eff date of ANDA's-CLOSED FDA-1995-P-0035 | FDA | Notice | NAD-Notice of Availability of Data | 1995-06-20T04:00:00Z | 1995 | 6 | 2008-05-16T23:07:26Z | 0 | 0 | 090000648055aed4 | |||
| FDA-1995-P-0051-0004 | FDA | Ban the Use of Lindane as a Treatment for Lice and Scabies-CLOSED FDA-1995-P-0051 | Acknowledgment Letter from FDA DMB to Public Citzen Health Research Group | Other | Acknowledgement Letter/Receipt | 1995-06-16T04:00:00Z | 1995 | 6 | 2025-09-15T21:41:17Z | 0 | 0 | 0900006480561e5c | |||
| FDA-2020-D-2006-0001 | FDA | FDA-2020-D-2006 | Guidance for Industry: Letter to Manufacturers, Importers, and Distributors of Imported Candy and Candy Wrappers | Other | Guidance | 1995-06-13T04:00:00Z | 1995 | 6 | 2020-09-23T04:00:00Z | 2024-11-06T23:39:05Z | 1 | 0 | 09000064848746a5 | ||
| FDA-1992-N-0049-0002 | FDA | Topical Drug Containing Benzoyl Peroxide; Additional Labeling FDA-1992-N-0049 | Topical Drug Products Containing Benzoyl Peroxide; Required Labeling; Extension of Comment Period | Notice | NEC-Notice of Extension | 1995-06-07T04:00:00Z | 1995 | 6 | 1995-06-07T04:00:00Z | 1995-07-18T03:59:59Z | 2010-02-25T18:34:06Z | 0 | 0 | 090000648052bd0a | |
| FDA-1995-P-0058-0001 | FDA | Enforce SMDA & Existing Regs Re: Mfgs of dental lubricants-CLOSED FDA-1995-P-0058 | Acknowledgment Letter from FDA DMB to Lerch, McDaniel & Kauo, PLC | Other | Acknowledgement Letter/Receipt | 1995-06-06T04:00:00Z | 1995 | 6 | 2025-09-09T09:00:16Z | 0 | 0 | 090000648056c3d3 | |||
| FDA-1995-P-0015-0001 | FDA | Amend Monograph on Antiemetic Drug Prods for OTC Human Use-CLOSED FDA-1995-P-0015 | Acknowledgement Letter from FDA HFA-305 to Akin, Grump, Strauss, Hauer & Feld, L.L.P | Other | Acknowledgement Letter/Receipt | 1995-05-30T04:00:00Z | 1995 | 5 | 2022-08-17T18:52:38Z | 0 | 0 | 0900006480558564 | |||
| FDA-1978-N-0018-0140 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Memorandum of Telephone Conversation Between Dr. Weinstock, Brown University & Jeanne Rippere, FDA April 18, 1995 | Other | Memorandum | 1995-05-11T04:00:00Z | 1995 | 5 | 2019-07-31T14:07:58Z | 0 | 0 | 090000648055a230 | |||
| FDA-1978-N-0018-0139 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Memorandum of Telephone Conversation Between Dr. J. Ferguson, Boots Contract Manufacturing & Jeanne Rippere, FDA May 1, 1995 | Other | Memorandum | 1995-05-11T04:00:00Z | 1995 | 5 | 2019-07-23T13:31:51Z | 0 | 0 | 090000648055a22d | |||
| FDA-1995-M-0055-0001 | FDA | PMA of Atakr Radio Frequency Catheter Ablation System FDA-1995-M-0055 | Medtronlc CardloRhythm; Premarket Approval of Atakr Radio Frequency Catheter Ablation System | Notice | Notice of Approval | 1995-05-03T04:00:00Z | 1995 | 5 | 1995-05-03T04:00:00Z | 1995-05-31T03:59:59Z | 2024-06-12T20:00:38Z | 0 | 0 | 090000648056c1d8 | |
| FDA-1981-N-0015-0001 | FDA | Antigingivitis & Antiplaque-Related Claims FDA-1981-N-0015 | Over-the-Counter Dental and Oral Health Care Drug Products for Antiplaque Use; Safety and Efficacy Review; Request for Data and Information | Notice | Requests for Information (RFI) | 1995-05-02T04:00:00Z | 1995 | 5 | 1995-05-02T04:00:00Z | 1991-03-19T04:59:59Z | 2023-03-31T12:55:51Z | 0 | 0 | 09000064805aecdc | |
| FDA-1981-N-0015-0004 | FDA | Antigingivitis & Antiplaque-Related Claims FDA-1981-N-0015 | Notice of Extension from FDA/CDER re over the couter dental and oral health care drug products for antiplaque use safty and efficacy review extension of submission period | Notice | Notice of Extension | 1995-05-02T04:00:00Z | 1995 | 5 | 1995-05-02T04:00:00Z | 1991-06-18T03:59:59Z | 2015-06-09T18:22:26Z | 0 | 0 | 09000064805aecfa | |
| FDA-1981-N-0015-0003 | FDA | Antigingivitis & Antiplaque-Related Claims FDA-1981-N-0015 | Notice of Extension from FDA CDER re Over the counter dental and oral health care drug products for antiplaque use safty and efficacy review extension of submission period | Notice | Notice of Extension | 1995-05-02T04:00:00Z | 1995 | 5 | 1995-05-02T04:00:00Z | 1991-06-18T03:59:59Z | 2015-05-27T16:23:27Z | 0 | 0 | 09000064805aecf9 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);